# Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation

> **NCT00572091** · PHASE1,PHASE2 · COMPLETED · sponsor: **Viacor** · enrollment: 4 (actual)

## Conditions studied

- Heart Failure
- Mitral Regurgitation

## Interventions

- **DEVICE:** PTMA Implant

## Key facts

- **NCT ID:** NCT00572091
- **Lead sponsor:** Viacor
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-04
- **Final completion:** 2008-11
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2008-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00572091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00572091, "Aachen Safety and Efficacy of the Percutaneous Transvenous Mitral Annuloplasty Device to Reduce Mitral Regurgitation". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00572091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*